Drug Interaction Report

Buprenorphine and Homatropine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Homatropine

Homatropaire
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 633 documented Buprenorphine interactions, 601 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Taken together, buprenorphine and homatropine can add up to slow your gut and bladder, so watch for severe constipation or trouble urinating and report it to your care team. This is a theoretical but serious risk that your team can manage.

Both of these medicines can slow down your gut and bladder. Buprenorphine is an opioid pain and addiction medicine, and opioids are well known for causing constipation. Homatropine is an anticholinergic (it's often used for the eyes or to relax cramping), and these drugs can also slow the bowels and make it harder to empty your bladder.

When you take them together, those effects can add up. In rare cases the gut can slow so much that it nearly stops, which is called paralytic ileus. This is mostly a theoretical concern, but it's worth knowing about. Watch for bad constipation, belly pain and bloating, or trouble urinating, and let your care team know. They can manage this easily.

Interaction: Additive anticholinergic and opioid-mediated reduction in GI motility and bladder tone, increasing the theoretical risk of severe constipation, urinary retention, and paralytic ileus.

  • Direction/mechanism: Pharmacodynamic (additive), not PK. Buprenorphine reduces gut motility via mu-opioid activity; homatropine adds antimuscarinic slowing. Neither is a prodrug relevant here.
  • Evidence: Theoretical; onset unspecified.
  • Severity: Major.
  • Management: Monitor for reduced gastric motility, abdominal distension, and urinary retention. Encourage hydration/bowel regimen; individualize dosing and consider alternatives per care team.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of paralytic ileus

Interaction Deep Dive

When buprenorphine is given together with an anticholinergic agent, the combination may lead to urinary retention or to severe constipation that progresses to paralytic ileus. In patients receiving buprenorphine alongside anticholinergic drugs, watch for indications of urinary retention or diminished gastric motility1.

Why it happens (mechanism)

Additive effects on gastric motility

How to manage this interaction

The good news is this is manageable. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.

  • Watch for warning signs: worsening constipation, no bowel movement for a few days, belly pain or bloating, or trouble passing urine.
  • Your care team may monitor you more closely and can adjust doses or suggest an alternative if needed.
  • Staying hydrated and asking about a bowel routine can help.
  • Call your pharmacist or doctor promptly if you notice these symptoms, and seek urgent care for severe belly pain, vomiting, or inability to urinate.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Buprenorphine and Homatropine together?

Taken together, buprenorphine and homatropine can add up to slow your gut and bladder, so watch for severe constipation or trouble urinating and report it to your care team. This is a theoretical but serious risk that your team can manage. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Buprenorphine and Homatropine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Buprenorphine and Homatropine interaction managed?

The good news is this is manageable. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Watch for warning signs: worsening constipation, no bowel movement for a few days, belly pain or bloating, or trouble passing urine. Your care team may monitor you more closely and can adjust doses or suggest an alternative if needed. Staying hydrated and asking about a… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Buprenorphine or Homatropine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.